Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Large scale production of Appethyl 2 as a biological appetite suppressant

Reference number
Coordinator Swepharm AB
Funding from Vinnova SEK 1 724 736
Project duration September 2018 - June 2021
Status Completed
Venture The strategic innovation programme Bioinnovation
Call Key Enabling Technologies for production of biobased products

Important results from the project

** Denna text är maskinöversatt ** Over two billion people today are considered overweight and about a quarter of these are considered to be obese. Spinach contains a protein fraction with a documented effect for appetite regulation and weight control. In the project, methods and techniques for reducing the daily dose of an ingredient based on this fraction have been developed. The daily dose can be reduced from 5 to 3 grams, which opens up for wider application of the ingredient in products with the aim of counteracting obesity.

Expected long term effects

** Denna text är maskinöversatt ** Results enabling reduction of the daily dose are that the fiber content and the particle size decreased, that more cells were opened up and that pigments associated with the active cell components increased. The effect is verified in a clinical study. A lower daily dose and results from studies of the ingredient´s heat resistance means that more product categories can be used for distribution to consumers. Products that consist of capsules can be distributed in fewer numbers and products that require heating, such as e.g. soups, can be developed.

Approach and implementation

** Denna text är maskinöversatt ** The development within the project has been driven by parties representing business development, technology development and research. All parties have a deep biochemical understanding while dealing with various aspects of the value chain. This has contributed to balanced positions being taken regarding the ingredient´s scientific anchoring, production costs, environmental consequences and business opportunities. The companies in the project are the same size and the communication paths have been uncomplicated between all three parties.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 1 September 2021

Reference number 2018-02745